48. ASSESSMENT OF THE FLUCTUATION OF ANTI-SARS – COV-2 IGG TITLE AND RELATED FACTORS IN COVID- 19 PATIENTS
Main Article Content
Abstract
Objective: To determine the change in anti-SARS-CoV-2 IgG concentration in CoVid-19 patients in Hanoi and to study the factors related to anti-SARS-CoV-2 IgG concentration in the above subjects.
Subjects and methods: Cross-sectional descriptive study at 4 time points: T0 (While being treated at the Central Tropical Hospital: 271 patients); T6 (After 6 months of infection: 250 patients); T12 (After 12 months of infection: 250 patients) and T18 (After 18 months of infection: 270 patients).
Results: Regarding age: group T0 has the highest average age: 55.5±16.4 (4 - 90); In terms of gender: women account for the majority in groups T6; T12 and T18, while men in group T0 are more numerous, accounting for 59.4%. BMI of the 4 stages are similar, mainly classified as normal (18 - 25); In terms of underlying diseases: Group T0 has the highest rate of underlying diseases, accounting for 60.89%, while T6 is 25.2%; group T12 is 22%; group T18 is 21.9%; In terms of vaccination history: Group T0 has received the least 32.1% of vaccinations; In terms of disease severity: Group T0 has the highest rate of severe and critical: 43.5% and 28.8%. Antibody concentration of group T0: 494.55 UI/ml (106.43- 1119.17); T6: 355.58 UI/ml
(241.95- 507.13); T12: 173.62 UI/ml (133.01- 229.47); T18: 74.9 UI/ml (53.13- 106.17).
Conclusion: Correlation was found between disease types and anti-SARS CoV-2 antibody concentration in group T0. Anti-SARS CoV-2 antibody concentration decreased over time but still existed up to 18 months after infection.
Article Details
Keywords
Covid-19, anti-SARS CoV-2 IgG, disease types, Son Tay General Hospital
References
[2] WHO (2003). Tình hình dịch COVID-19 trên thế giới và khuyến nghị của Tổ chức Y tế thế giới. https://vncdc.gov.vn/tinh-hinh-dich-covid-19-tren-the-gioi-va-khuyen-nghi-cua-to-chuc-yte-the-gioi-who-nd17305.html,
[3] M. I. de Oliveira, M. R. Aciole, P. A. F. Neves và cộng sự (2024). A stronger antibody response in increased disease severity of SARS-CoV-2. BMC Infectious Diseases, 24 (1), 17.
[4] S. Prato, M. E. Paladino, M. A. Riva và cộng sự (2021). COVID-19 Vaccination and Asymptomatic Infection: Effect of BNT162b2 mRNA Vaccine on the Incidence of COVID-19 and Duration of Sick Leave Among Healthcare Workers. Journal of occupational and environmental medicine, 63 (12), e868-e870.
[5] S. Hoshida, N. Koeda, H. Hattori và cộng sự (2022). Age- and sex-based changes in spike protein antibody status after SARS-CoV-2 vaccination and effect of past-infection in healthcare workers in Osaka. BMC Infect Dis, 22 (1), 709.
[6] R. Varnai, T. Molnar, L. Zavori và cộng sự (2022). Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms. Vaccines, 10 (2), 165.
[7] T. B. Onyango, F. Zhou, G. Bredholt và cộng sự (2023). SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients. Front Immunol, 14, 1287388.
[8] D.-Y. Lin, F. Abi Fadel, S. Huang và cộng sự
(2023). Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections. JAMA Network Open, 6 (9), e2335077-e2335077.
[9] S. L. S. Penetra, H. F. P. Santos, P. C. Resende và cộng sự (2023). SARS-CoV-2 Reinfection Cases in a Household-Based Prospective Cohort in Rio de Janeiro. J Infect Dis, 228 (12), 1680-1689.